First-line treatment for patients with CML in chronic phase: Second-generation TKIs are the therapy of choice

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
JournalONCOLOGY (United States)
Volume27
Issue number8
StatePublished - Jan 1 2013

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{29dc8641c73f406b9542773cc5bae5a5,
title = "First-line treatment for patients with CML in chronic phase: Second-generation TKIs are the therapy of choice",
author = "Jorge Cortes",
year = "2013",
month = "1",
day = "1",
language = "English (US)",
volume = "27",
journal = "ONCOLOGY (United States)",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",
number = "8",

}

TY - JOUR

T1 - First-line treatment for patients with CML in chronic phase

T2 - Second-generation TKIs are the therapy of choice

AU - Cortes, Jorge

PY - 2013/1/1

Y1 - 2013/1/1

UR - http://www.scopus.com/inward/record.url?scp=84881285253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881285253&partnerID=8YFLogxK

M3 - Comment/debate

C2 - 24133826

AN - SCOPUS:84881285253

VL - 27

JO - ONCOLOGY (United States)

JF - ONCOLOGY (United States)

SN - 0890-9091

IS - 8

ER -